Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONT... by Marathe, Kalyani, Teng, Joyce M. C., Guenthner, Scott, Bunick, Christopher G., Kempers, Steven, Eads, Kimmie, Castelo-Soccio, Leslie, Mendelsohn, Alan M., Raiz, Jessica, Murrell, Dédée F.

Get full text

51523 The Phase 3 Vehicle-Controlled ASCEND Trial of Polyethylene Glycol Based Topical Isotretinoin (TMB-001 0.05% ointment) for Treatment of X-Linked and Autosomal Recessive Conge... by Bunick, Christopher, Huynh, Thy N., MS, Jackson, Lee, Lara Wine, Kempers, Steven E., Mendelsohn, Alan M., Eursken, Brenda, Ahson, Anum, Raiz, Jessica, Teng, Joyce MC

Get full text

The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosom... by Teng, Joyce M.C., Bunick, Christopher G., Guenthner, Scott, Murrell, Dedee F., Marathe, Kalyani, Kempers, Steven, Eads, Kimmie, Mendelsohn, Alan M., Raiz, Jessica, Tavakkol, Amir, Castelo-Soccio, Leslie

Get full text

Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal... by Murrell, Dedee F, Teng, Joyce M C, Guenthner, Scott, Marathe, Kalyani, Kempers, Steven, Eads, Kimmie, Castelo-Soccio, Leslie, Mendelsohn, Alan M, Raiz, Jessica, Bunick, Christopher G

Get full text

Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CO... by Bunick, Christopher G, Teng, Joyce M C, Guenthner, Scott, Marathe, Kalyani, Kempers, Steven, Eads, Kimmie, Castelo-Soccio, Leslie, Mendelsohn, Alan M, Raiz, Jessica, Murrell, Dédée F

Get full text